Cytometer supports cell studies at ICR

Following the acquisition of the Celigo Imaging Cytometer product earlier this year, Brooks Life Science Systems has developed new and improved applications for use in cell line generation and oncology research including tumour growth analysis in drug screening.

Dr Suzanne Eccles, Reader in Tumour Biology at the Institute of Cancer Research, Sutton, UK commented, “Celigo has been essential to our work validating 3D models of tumor growth, invasion and angiogenesis. We now have robust, high-throughput growth assays, with results for 96-well plates in minutes compared with standard automated microscopy-based image analysis, and we have been able to develop novel quantitative, measurements of tumour invasion.

By using the Celigo in our drug discovery research we have more clinically relevant models for drug evaluation which are contributing to a reduction in the amount of in vivo testing being performed.”

Clint Haris, Senior Vice President, General Manager, Brooks Life Science Systems added, “Cell analysis is a fast moving field that requires versatile instrumentation capable of meeting challenging demands. The development of these new applications is ensuring that Celigo continues to meet the needs of our customers and highlights our commitment to supporting the field of cell analysis.”